Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections

NEW HAVEN, Conn. – October 24, 2016 – Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced today that it has submitted New Drug Applications (NDAs) to the U.S. Food and Drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news